TipRanks
Go Ultimate55% OFF

EMulate Therapeutics Inc Insider Profile

4 Followers

EMulate Therapeutics Inc, Shareholder at Hapbee Technologies, holds 10.50M shares in Hapbee Technologies (Ticker: HAPBF). Most recently, EMulate Therapeutics Inc Bought 10,500,000 shares of Hapbee Technologies on Oct 26, 2026 for an estimated value of $682.50K.

EMulate Therapeutics Inc's Trading History

HAPBF
Hapbee Technologies
Oct 26, 2026ShareholderInformative Buy682.50K$231.00K
HAPBF
Insider Shares: 10.50M (448.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 26, 2026Informative BuyC$682.50K10,500,000C$0.06――

You May Also Like

EMulate Therapeutics Inc insider profile FAQ

What stocks does EMulate Therapeutics Inc hold?
EMulate Therapeutics Inc holds: HAPBF stocks.
What was EMulate Therapeutics Inc’s latest transaction?
EMulate Therapeutics Inc’s latest transaction was an Informative Buy of $682.50K.
What is EMulate Therapeutics Inc's role in Hapbee Technologies?
EMulate Therapeutics Inc's role in Hapbee Technologies is Shareholder.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.